Amy Ross joined the PLOS Medicine team in September 2012 and has a strong interest in open access publishing and global health. She completed an undergraduate degree in Neuroscience from the University of Otago in 2000, followed by a PhD in Psychiatry from the University of New South Wales, where she focused on using neuroimaging biomarkers for the prediction of cognitive impairment after stroke. She then moved to the United States for a postdoctoral research position at Mclean Hospital/ Harvard Medical School, where she was involved in clinical research studies investigating novel treatments for bipolar disorder, as well as neuroimaging studies measuring functional and structural brain changes in psychiatric disorders and addiction. In 2007, she moved to San Francisco and began working as a Research Scientist at Omneuron, a biotechnology company in Menlo Park. At Omneuron, she was involved in developing and testing non-pharmacological treatments for chronic pain, depression, and addiction using real-time functional MRI biofeedback. In her spare time, she loves traveling, exploring the outdoors, yoga, and since moving to the US has become a huge baseball fan.